东北证券研报指出，联影医疗经过十余年快速发展，已成为中国高端医学影像设备领域的领军企业，形 成了覆盖计算机断层成像（CT）、磁共振（MR）、分子影像（MI）、X 射线（XR）、放射治疗 （RT）五大产品线的核医学设备布局，积极推动人工智能技术融合与智能化转型。各省市大型医用设 备集采政策陆续落地，国产替代显著提速。CT、MR、MI 产品线出海放量，在北美市场、欧洲市场渗 透高端医疗装备市场，在印度新装机市场位列前位。公司是中国医疗影像设备行业龙头，构筑"高端突 破+基盘稳固"的双轮驱动格局，国内市占率梯度突破，海外实现高端突破和新兴区域渗透。给予公 司"买入"评级。 ...

Core Viewpoint - GE Healthcare is undergoing organizational adjustments in China, including job cuts in the CT business line and a lower-than-expected reduction in the MR business line, in response to changing market conditions [1] Group 1: Organizational Changes - Job cuts are being implemented in the CT business line, while the MR business line's layoffs are below the rumored 10% [1] - The adjustments are aimed at optimizing the organizational structure to better serve customers and drive long-term business growth [1] Group 2: Commitment to the Market - GE Healthcare emphasizes that the overall commitment to the Chinese market remains unchanged despite the personnel changes [1] - The company continues to recruit and invest in key areas closely related to its business strategy for future development [1]